Ragosa Mark bought KNSA
December 8, 2025 · Form 4 insider transaction
Ragosa Mark bought 16,165 shares of Kiniksa Pharmaceuticals International, plc at $11.97 per share, a transaction worth $193.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
16,165
Price
$11.97
Total value
$193.5K
InsiderRagosa Mark
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeM: Option exercise
Transaction dateDecember 8, 2025
Filing dateDecember 10, 2025
Shares owned after63,415
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.